Johnson & Johnson (JNJ) Accounts Payables (2009 - 2026)

Johnson & Johnson's Accounts Payables history runs 18 years deep, the most recent figure standing at $10.5 billion for Q1 2026.

• In Q1 2026, Accounts Payables rose 9.59% year-over-year to $10.5 billion; the TTM figure through Mar 2026 stood at $10.5 billion (up 9.59% YoY), while the FY2025 annual figure was $12.0 billion, up 16.29% from the prior year.
• Accounts Payables came in at $10.5 billion for Q1 2026 at Johnson & Johnson, down from $12.0 billion in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $12.0 billion in Q4 2025 to a low of $8.2 billion in Q1 2024.
• A 5-year average of $9.8 billion and a median of $9.7 billion in 2022 frame the typical range for Accounts Payables.
• Across the five-year window, Accounts Payables retreated 17.71% in 2023 and increased 16.77% in 2025, its largest moves.
• Johnson & Johnson's Accounts Payables stood at $10.2 billion in 2022, then decreased by 5.13% to $9.6 billion in 2023, then rose by 7.05% to $10.3 billion in 2024, then advanced by 16.29% to $12.0 billion in 2025, then slipped by 12.77% to $10.5 billion in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $10.5 billion, $12.0 billion, and $9.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison